SANGAMO THERAPEUTICS, INC. Other Non-Current Liabilities
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Other Non-Current Liabilities of $580.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-05-14
- 2026-03-31: Other Liabilities, Noncurrent $580.00K.
- 2025-12-31: Other Liabilities, Noncurrent $580.00K.
- 2025-09-30: Other Liabilities, Noncurrent $977.00K.
- 2025-06-30: Other Liabilities, Noncurrent $962.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-03-31 | $580.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $580.00K 10-Q · filed 2026-05-14 |
| 2025-09-30 | $977.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $962.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $933.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $933.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.24M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.22M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.21M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.19M 10-K · filed 2025-03-17 |
| 2023-09-30 | $1.32M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $1.27M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.23M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.21M 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.31M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.28M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.24M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.22M 10-K · filed 2023-02-23 |
| 2021-09-30 | $7.63M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.42M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $7.23M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $7.01M 10-K · filed 2022-02-24 |
| 2020-09-30 | $6.24M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $6.05M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $5.88M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.71M 10-K · filed 2021-02-24 |
| 2019-09-30 | $5.54M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.29M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.91M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.96M 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.73M 10-Q · filed 2018-11-08 |